Your browser doesn't support javascript.
loading
Twelve-month short-term safety and visual-acuity results from a multicentre prospective study of epiretinal strontium-90 brachytherapy with bevacizumab for the treatment of subfoveal choroidal neovascularisation secondary to age-related macular degeneration.
Avila, M P; Farah, M E; Santos, A; Duprat, J P; Woodward, B W; Nau, J.
Affiliation
  • Avila MP; Centro Brasileiro de Cirurgia de Olhos, CEP 74210-010 Goiânia-Goiás, Brazil.
Br J Ophthalmol ; 93(3): 305-9, 2009 Mar.
Article in En | MEDLINE | ID: mdl-19019935

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Strontium Radioisotopes / Radiopharmaceuticals / Choroidal Neovascularization / Angiogenesis Inhibitors / Macular Degeneration / Antibodies, Monoclonal Type of study: Clinical_trials / Observational_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Br J Ophthalmol Year: 2009 Document type: Article Affiliation country: Brazil Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Strontium Radioisotopes / Radiopharmaceuticals / Choroidal Neovascularization / Angiogenesis Inhibitors / Macular Degeneration / Antibodies, Monoclonal Type of study: Clinical_trials / Observational_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Br J Ophthalmol Year: 2009 Document type: Article Affiliation country: Brazil Country of publication: United kingdom